Aadi Bioscience, Inc.
AADI
$1.91
-$0.005-0.26%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -8.76% | 21.03% | 40.38% | 80.45% | 154.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.76% | 21.03% | 40.38% | 80.45% | 154.31% |
| Cost of Revenue | 24.03% | 42.78% | 34.39% | 81.85% | 64.71% |
| Gross Profit | -58.28% | -68.82% | -29.43% | 79.85% | -20.40% |
| SG&A Expenses | -5.24% | -6.86% | 13.17% | 17.69% | 22.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.58% | 16.14% | 23.48% | 42.46% | 40.76% |
| Operating Income | -15.97% | -14.49% | -18.71% | -33.54% | -21.80% |
| Income Before Tax | -20.14% | -16.86% | -12.63% | 1.58% | -9.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.14% | -16.93% | -12.63% | 1.63% | -9.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.14% | -16.93% | -12.63% | 1.63% | -9.86% |
| EBIT | -15.97% | -14.49% | -18.71% | -33.54% | -21.80% |
| EBITDA | -15.93% | -14.55% | -18.51% | -33.49% | -22.18% |
| EPS Basic | -19.62% | -16.38% | 11.09% | 23.26% | 14.46% |
| Normalized Basic EPS | -19.62% | -16.32% | 11.10% | 3.53% | 14.47% |
| EPS Diluted | -19.62% | -16.38% | 11.09% | 23.26% | 14.46% |
| Normalized Diluted EPS | -19.62% | -16.32% | 11.10% | 3.53% | 14.47% |
| Average Basic Shares Outstanding | 0.44% | 0.47% | 26.69% | 28.18% | 28.44% |
| Average Diluted Shares Outstanding | 0.44% | 0.47% | 26.69% | 28.18% | 28.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
